SCHEMBL25547933

SCHEMBL25547933

O=C1CCc2cc(NC(=O)c3cccc(C(O)Cc4cnccn4)c3)ccc2N1

nearest known ligand 0.47

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MAP4K1 Q92918 1/20 0.47
▸ ROCK2 O75116 4/20 0.45
▸ ULK1 O75385 2/20 0.44
▸ ALDH1A2 O94788 3/20 0.43
▸ KIF11 P52732 2/20 0.42
▸ HDAC3 O15379 1/20 0.41
▸ HDAC4 P56524 1/20 0.41
▸ HDAC1 Q13547 1/20 0.41
▸ HDAC2 Q92769 1/20 0.41
▸ HDAC8 Q9BY41 1/20 0.41
▸ HDAC6 Q9UBN7 1/20 0.41
▸ HDAC9 Q9UKV0 1/20 0.41
▸ CRBN Q96SW2 2/20 0.40
▸ CYP1A2 P05177 2/20 0.40
▸ CYP3A4 P08684 1/20 0.40
▸ CYP19A1 P11511 1/20 0.40
▸ PTK2 Q05397 1/20 0.39
▸ PTK2B Q14289 1/20 0.39
▸ CYP2C9 P11712 1/20 0.38
▸ CYP11B1 P15538 1/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL18789762 0.81 MAP4K1 (0.51) MAP4K1ROCK2ULK1ALDH1A2KIF11
SCHEMBL25547937 0.77 MAP4K1 (0.43) MAP4K1ROCK2ULK1ALDH1A2HDAC3
SCHEMBL26441329 0.74 MAP4K1 (0.51) MAP4K1ROCK2ALDH1A2KIF11HDAC3
SCHEMBL9378760 0.74 MAP4K1 (0.60) MAP4K1ROCK2ALDH1A2KIF11HDAC3
SCHEMBL10365448 0.74 MAP4K1 (0.65) MAP4K1ROCK2ALDH1A2KIF11HDAC3
SCHEMBL25547935 0.72 MAP4K1 (0.45) MAP4K1ROCK2ULK1ALDH1A2KIF11
SCHEMBL31139953 0.71 MAP4K1 (0.50) MAP4K1ROCK2ULK1ALDH1A2KIF11
SCHEMBL31680533 0.71 NPC1 (0.56) MAP4K1ROCK2ALDH1A2KIF11HDAC3
SCHEMBL26441313 0.71 MAP4K1 (0.53) MAP4K1ROCK2ALDH1A2KIF11HDAC3
SCHEMBL26441302 0.70 MAP4K1 (0.53) MAP4K1ULK1ALDH1A2KIF11HDAC3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3365330-B1 PHARMACOPHORES, COMPOUNDS AND METHODS HAVING APPLICATION IN THE TREATMENT OF CANCER THROUGH INHIBITION OF CYP17A1 AND CYP19A1 MANGOSUTHU UNIV OF TECHNOLOGY (ZA) 2023-06-07 — — EP disclosed
EP-3365819-B1 PHARMACOPHORES, COMPOUNDS AND METHODS HAVING APPLICATION IN THE TREATMENT OF CANCER THROUGH INHIBITION OF CYP17A1 AND CYP19A1 MANGOSUTHU UNIV OF TECHNOLOGY (ZA) 2023-06-07 — — EP disclosed
Send feedback